Recent Press Releases
August 03, 2010
Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
July 23, 2010
Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA® Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
June 16, 2010
Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA® Demonstrating
Statistically Significant Improvement in Response in Rheumatoid Arthritis Patients
AGA Institute and Horizon Pharma Launch "Connect to Protect" Program to Educate Physicians and Consumers on Risks Associated with NSAID Use
